Publications by authors named "Xiandi Meng"

Claim this Profile
C
Cationic lipid-modified PEG-PLGA nanoparticles facilitate effective dendritic cell reprogramming to alleviate T cell-mediated autoimmunity in EAE.
He Li, Xiuxiu Cong, Huizhu Tan, Jialiang Wang, Haochuan Liu, Xiandi Meng, Tianmeng Sun

Biomaterials· April 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled Delivery of C-C Motif Chemokine Ligand 25 by a Hydrogel for Tumor Microenvironment Remodeling in Triple Negative Breast Cancer.
Meng Guan, Junfeng Ding, Ge Zhu, Kuirong Mao, Xiandi Meng, Mengfei Zhao, Tianmeng Sun

Acta Biomater· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy.
Jiaxuan Li, Kuirong Mao, Xiandi Meng, Jialiang Wang, Mengfei Zhao, Tianmeng Sun

Acta Biomater· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy.
Kuirong Mao, Huizhu Tan, Xiuxiu Cong, Ji Liu, Yanbao Xin, Meng Guan, Xiandi Meng, Tianmeng Sun

Acta Pharm Sin B· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing ovarian cancer treatment with maleimide-modified Pt(IV) prodrug nanoparticles.
Yiting Bai, Zhenpeng Wang, Dongzhen Liu, Xiandi Meng, Haorui Wang, Tianmeng Sun

Mater Today Bio· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases.
Xiandi Meng, Ge Zhu, Yong-Guang Yang, Tianmeng Sun

Biomed Pharmacother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impacts of cationic lipid-DNA complexes on immune cells and hematopoietic cells .
Xiuxiu Cong, Huizhu Tan, Yue Lv, Kuirong Mao, Yanbao Xin, Xiandi Meng, Meng Guan, Tianmeng Sun

Biomater Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of a mutant CD47 protects against phagocytosis without inducing cell death or inhibiting angiogenesis.
Lu Xu, Xiaodan Wang, Ting Zhang, Xiandi Meng, Wenjie Zhao

Cell Rep Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maleimide as the PEG end-group promotes macrophage-targeted drug delivery of PEGylated nanoparticles in vivo by enhancing interaction with circulating erythrocytes.
Xin Wang, Xiandi Meng, Kuirong Mao, Hongmei Chen, Xiuxiu Cong, Tianmeng Sun

Biomaterials· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosafety risk assessment of gold and aluminum nanoparticles in tumor-bearing mice.
Ge Zhu, Zhihan Li, Yuning Zhang, Xiandi Meng, Meng Guan, Tianmeng Sun

APL Bioeng· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A biocompatible nanoparticle-based approach to inhibiting renal ischemia reperfusion injury in mice by blocking thrombospondin-1 activity.
Yue Hou, Yanbao Xin, Shuhan Liu, Yong Li, Xiandi Meng, Tianmeng Sun

Am J Transplant· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vibratome sectioning of tumors to evaluate the interactions between nanoparticles and the tumor microenvironment ex-vivo.
Shuhan Liu, Juechao Zhang, Ning-Ning Zhang, Xiandi Meng, Kun Liu, Tianmeng Sun

Front Bioeng Biotechnol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy.
Shuhan Liu, Ji Liu, Haisong Li, Kuirong Mao, Haorui Wang, Xiandi Meng, Tianmeng Sun

Biomaterials· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant blockade of CXCR4 improves leukemia complete remission rates and donor stem cell engraftment without aggravating GVHD.
Long Su, Ming-Hui Fang, Jun Zou, Su-Jun Gao, Xiao-Yi Gu, Xian-Di Meng

Cell Mol Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Host-Defense-Peptide-Mimicking Synthetic Polypeptides Effectively Enhance Antitumor Immunity through Promoting Immunogenic Tumor Cell Death.
Ye Wang, Wei Shen, Shuhan Liu, Ge Zhu, Xiandi Meng, Tianmeng Sun

Macromol Biosci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cationic Liposome/DNA Complexes Mediate Antitumor Immunotherapy by Promoting Immunogenic Tumor Cell Death and Dendritic Cell Activation.
Xiuxiu Cong, Huimin Tian, Shuhan Liu, Kuirong Mao, Hongmei Chen, Xiandi Meng, Tianmeng Sun

ACS Appl Mater Interfaces· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9 T cells.
Hongmei Chen, Xiuxiu Cong, Chenxi Wu, Xuan Wu, Jialiang Wang, Xiandi Meng, Tianmeng Sun

Sci Adv· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles.
Ji Liu, Jin Chang, Ying Jiang, Xiandi Meng, Tianmeng Sun

Adv Mater· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis